Clinical studies recruiting near Budapest

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Óbudai Egészségügyi Centrum · AbbVie · NCT06602479 KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Orszagos Koranyi Pulmonologiai Intezet ( Site 0060) · Merck Sharp & Dohme LLC · NCT04165070 International Leukemia Target Board
Phase N/A · Semmelweis · Princess Maxima Center for Pediatric Oncology · NCT05270096 A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · Semmelweis Egyetem · Janssen Research & Development, LLC · NCT06449651 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Semmelweis Egyetem · Eli Lilly and Company · NCT07218380 Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NA · Semmelweis University · University Hospital, Geneva · NCT06207383 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 3480001 · Sanofi · NCT06867094 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · University Semmelweis · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Semmelweis Egyetem · Bristol-Myers Squibb · NCT06929273 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Del-Pesti Centrumkorhaz - Orszagos Hematologiai es Infektolo · Miltenyi Biomedicine GmbH · NCT04844866 Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due
NA · Semmelweis University Center · iVascular S.L.U. · NCT07357285 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Orszagos Koranyi Pulmonologiai Intezet · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0129 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · Semmelweis University · University of Oxford · NCT05169333 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Trial Pharma Kft · Amgen · NCT07037433 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Geomedical Egészségügyi Központ · Eli Lilly and Company · NCT07483099 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Óbudai Egészségügyi Centrum · Eli Lilly and Company · NCT07415044 Speech of Kids After Neonatal Encephalopathy
Phase N/A · Semmelweis University · Semmelweis University · NCT07136636 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Országos Onkológiai Intézet ( Site 1603) · Merck Sharp & Dohme LLC · NCT07216703 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · Semmelweis University-Internal Medicine and Haematology · argenx · NCT06544499 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Országos Onkológiai Intézet · Eli Lilly and Company · NCT06890598 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Obudai Egeszsegugyi Centrum Kft · Janssen Research & Development, LLC · NCT07499232 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 5101 · Turning Point Therapeutics, Inc. · NCT03093116 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Gottsegen Gyorgy Orszagos Kardiovaszkularis Intezet - Gyerme · Bayer · NCT07192952 Associations of Autistic Traits and Feeding Difficulties
Phase N/A · Bethesda Children's Hospital · Semmelweis University · NCT07188870 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Semmelweis Egyetem · Eli Lilly and Company · NCT06937086 Evaluation of the CONDA Stent Retriever in Acute Ischemic Stroke
NA · Semmelweis University Hospital · Anaconda Biomed S.L. · NCT07174505

Look up another city

Look up another condition